Matrix Medical Network Acquires Biocerna
October 2, 2020
Matrix Medical Network acquired Biocerna, a CLIA-certified and CAP-accredited clinical laboratory based in Fulton, Maryland, to integrate in-house diagnostic and COVID-19 testing capabilities. The acquisition expands Matrix's ability to deliver timely testing services to its network of clinicians and mobile health clinics, supporting employer testing, clinical trial support, and other client-facing diagnostic services.
- Buyers
- Matrix Medical Network
- Targets
- Biocerna
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Matrix Sciences Acquires Cherney Microbiological Services, Ltd.
May 19, 2021
Professional Services
Matrix Sciences has acquired Cherney Microbiological Services, Ltd., expanding its network of agri‑food testing laboratories and strengthening service coverage in the Wisconsin region. The deal brings Cherney's ISO‑accredited microbiology capabilities and Green Bay location into Matrix's network of 19 facilities and 32 dedicated vehicles to better serve regional food manufacturers.
-
CellCarta Acquires Biogazelle
December 14, 2021
Biotechnology
CellCarta has acquired Biogazelle, a Ghent-based leader in digital PCR (dPCR), qPCR and RNASeq assay development, to strengthen and expand its genomic capabilities. The acquisition creates a Center of Excellence for complex genomic biomarker assay development within CellCarta and broadens its service offering for pharmaceutical and biotech clients across discovery and clinical stages.
-
MLM Medical Labs Acquires MD Biosciences, Inc.
October 27, 2020
Healthcare Services
MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.
-
CERTANIA Acquires Bioarray Genetic Diagnosis
July 9, 2025
Healthcare Services
CERTANIA, a Munich-based Testing, Inspection and Certification (TIC) group, has acquired Spanish genetic diagnostics lab Bioarray, which will join CERTANIA’s global network. Bioarray — headquartered in Elche (Alicante) — will continue to be led by cofounder Andrés Antón Salas and will leverage CERTANIA’s platform to expand its genomic diagnostics and research services internationally.
-
Mesa Laboratories Acquires Agena Bioscience
September 14, 2021
Medical Devices
Mesa Laboratories, Inc. (NASDAQ:MLAB) entered into a definitive agreement to acquire Agena Bioscience, Inc. for $300 million in cash. Agena, a San Diego–based molecular diagnostics and genomics tools company, is expected to add roughly $63–67 million of revenue (about 65% recurring) in the first 12 months and will form Mesa’s new Clinical Genomics Division.
-
CellBio Scientific Acquires BioChain
May 1, 2025
Biotechnology
CellBio Scientific, a provider of life science tools and research services, has acquired BioChain, a biospecimen collection, preparation, and analysis company based in Newark, California. The acquisition expands CellBio Scientific's capabilities in spatial genomics and biospecimen workflows, consolidating BioChain with System Biosciences and Acepix Biosciences to create a broader translational research platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.